Court Upholds Willful Patent Infringement Verdict Against Alcon, Awards Sight Sciences $34M Plus Ongoing Royalties
SGHT sits 99% above its 52-week low of $2.03.
Summary
A U.S. District Court upheld a jury's verdict of willful patent infringement against Alcon, awarding Sight Sciences $34 million in past damages and a 10% ongoing royalty on Hydrus® Microstent revenue through 2028.
Key Events · Legal and Risk Events · SGHT
-
Court Upholds Willful Infringement Verdict
The U.S. District Court for the District of Delaware preserved the jury's verdict that Alcon willfully infringed three Sight Sciences patents related to the Hydrus® Microstent.
-
Significant Monetary Damages Awarded
The court awarded Sight Sciences $34 million in monetary damages for past infringement, plus supplemental damages and interest, which is a substantial amount relative to the company's market capitalization.
-
Ongoing Royalty Stream Established
An ongoing royalty of 10% of Hydrus® Microstent revenue was awarded through November 10, 2028, providing a new, long-term revenue source.
-
Legal Hurdles Remain
The final judgment is subject to appeal by Alcon, and no monetary damages will be recovered until appeals are exhausted. Additionally, ongoing *ex parte* reexamination petitions by Alcon could affect the ability to collect.
Analysis · SGHT · Industrial Applications And Services
This filing announces a critical legal victory for Sight Sciences, with a U.S. District Court upholding a jury's verdict of willful patent infringement against Alcon. The award of $34 million in past damages, representing over 16% of Sight Sciences' current market capitalization, provides a substantial potential capital infusion. Furthermore, the establishment of a 10% ongoing royalty on Alcon's Hydrus® Microstent revenue through November 2028 creates a significant future revenue stream. This development is particularly impactful given the company's recent financial baseline, which included a reduced net loss and workforce reductions, suggesting this award could materially improve its financial stability and operational runway. Investors should monitor the progress of Alcon's appeals and the ongoing *ex parte* reexamination proceedings, as these could affect the timing and ultimate collection of the awarded funds.
How filings like this one have moved
In the 30 days to Sep 20, 2026, 39.1% of the 343 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGHT was trading at $4.03 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $209.5M. The 52-week trading range was $2.03 to $9.24. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.